PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+ T cells in vitro
Abstract
Highly enriched preparations of human CD3+CD4+ T-lymphocytes were stimulated with mitogen or OKT3 to determine the capacity of K-562 cells to function as accessory cells. Phorbol 12-myristate 13-acetate (PMA)-treated K-562 cells were induced to differentiate along the megakaryocytic lineage and could supplant monocyte-accessory cell function. Intracytoplasmic analysis of interleukin-4 (IL-4) and interferon-γ (IFN-γ) established that IL-4, and not IFN-γ, was preferentially produced by the activated lymphocytes. This polarized stimulation is compatible with a type 2 or humoral immune response of purified T cells co-cultured with differentiated K-562 cells in vitro, and may have implications in immunoregulation due to disease progression.
Keywords: Human CD4 cells, Phorbol 12-myristate 13-acetate, K-562, Th1, Th2
Abbreviations: APC, antigen-presenting cell, CML, chronic myelogenous leukemia, ConA, concanavalin A, FBS, fetal bovine serum, FITC, fluoroscein isothiocyanate, IFN-γ, interferon-γ, IL, interleukin, KLH, keyhole limpet hemocyanin, MHC, major histocompatibility complex, PBS, phosphate-buffered saline, PE, phycoerythrin, PHA, phytohemagglutinin, PMA, phorbol 12-myristate 13-acetate, TCR, T cell receptor, Th1, T helper lymphocyte type 1, Th2, T helper lymphocyte type 2
To access this article, please choose from the options below
PII: S0145-2126(00)00082-5
doi:10.1016/S0145-2126(00)00082-5
© 2000 Elsevier Science Ltd. All rights reserved.
